Psychotropic medication nonadherence in populations with Serious Mental Illness (SMI) can lead to inadequate symptom control, reduced treatment effectiveness, significant relapse risk, and increased risk of death (Semahegn, 2020). Nonadherence to medication also results in increased healthcare...
View our extensive library of over 2,000 articles for vital mental health and substance use disorder education, information, support, advocacy, and quality resources
Reach an Engaged Behavioral Health Audience
Connect with 30,000+ average monthly users and 420,000 annual pageviews across a trusted platform serving professionals, families, and individuals in the mental health and substance use disorder communities.
BHN Summer 2026 Issue
“The Role of Policy and Advocacy in Shaping Behavioral Health Care Systems"
